Patent ID: 7790205
Filing Date: 2010-09-07
Classification: A61K,A61P

Abstract:
1. A method of treating a pathological condition in a mammal, the method comprising administering to mammal suffering from the pathological condition a composition comprising a therapeutically effective amount of a first component selected from the group consisting of dihydro-isohumulone, dihydro-isocohumulone, dihydro-isoadhumulone, tetrahydro-isohumulone, tetrahydro-isocohumulone, tetrahydro-isoadhumulone, hexahydro-isohumulone, hexahydro-isocohumulone, and hexahydro-isoadhumulone and a therapeutically effective amount of a second component selected from the group consisting of rosemary, an extract derived from rosemary, a compound derived from rosemary, oleanolic acid and ursolic acid, wherein a) the composition comprises from about 50 mg to about 7500 mg of the first component, and b) said pathological condition is selected from the group consisting of inflammation, inflammation-associated disorders, arthritis, asthma, bronchitis, menstrual cramps, tendonitis, bursitis, skin-related conditions, gastrointestinal conditions, cancer, ophthalmic diseases, pulmonary inflammation, nervous system disorders, allergic rhinitis, respiratory distress syndrome, endotoxin shock syndrome, atherosclerosis, and central nervous damage; thereby treating said pathological condition.